Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Mechanism driven adaptation of smart hydrogels to the osteoarthritis pathological microenvironment

You H., Liu Q., Zhang J., Zheng P., Dou W., Yao Y.

Narrative Review on Osteoarthritis, Cartilage Damage, published in Front Bioeng Biotechnol (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Front Bioeng Biotechnol (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41953562
PMCID
PMC13054226
DOI
10.3389/fbioe.2026.1751293
Citations
1

Abstract (original English)

Osteoarthritis (OA) arises from interconnected pathological processes, including persistent inflammation, mitochondrial dysfunction, cartilage matrix degeneration, and abnormal neurovascular remodeling. Current clinical care remains largely symptomatic and targets only a narrow set of mechanisms, which limits modification of the disease course. Smart hydrogels, owing to their injectability, biocompatibility, and responsiveness to intrinsic and extrinsic cues, offer notable advantages for OA therapy. By sensing changes in the joint microenvironment, they enable precise control of drug release in space and time and shift treatment from symptomatic control toward targeted repair. This review first synthesizes the roles and interactions of the principal mechanisms that shape the OA microenvironment. It then surveys recent advances in smart hydrogels for OA, with emphasis on applications that suppress inflammation, regulate mitochondrial function, promote cartilage repair, and modulate abnormal neurovascular remodeling. Design strategies for responsive crosslinking networks and their integration with delivery vehicles such as bioactive molecules, nanomaterials, and exosomes are also outlined. Remaining challenges are discussed, including harmonized efficacy endpoints, durability and safety in vivo , scalable manufacturing, and translation to clinical practice, together with opportun

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research